Join leading cardiologists and medical experts in this comprehensive conference recording from the 2023 Canadian Cardiac Sarcoidosis Symposium (C2S2) as they explore the latest developments in cardiac sarcoidosis diagnosis and treatment. Learn about advanced PET imaging techniques, screening protocols for cardiac involvement in extra-cardiac sarcoidosis patients, and current treatment strategies from Dr. Rob Beanlands, Dr. Vasilis Kouranos, and Dr. David Birnie. Gain insights into regional treatment approaches from experts in Montreal and London, and understand sudden cardiac death risk stratification and device therapy guidelines presented by Dr. Jordana Kron. Examine real-world applications through three detailed case discussions led by Dr. Alessandro De Bortoli, Dr. Mario Senechal, and Dr. Genevieve Giraldeau, offering practical perspectives on patient care and treatment decisions in cardiac sarcoidosis management.
Overview
Syllabus
- PET imaging of CS: update on techniques, indications, recent guidelines, and future directions. Dr. Rob Beanlands, Ottawa, Canada
- Screening for cardiac involvement in patients with extra-cardiac sarcoidosis. Which test s with what expected results, what to do with the result, and how often to repeat screening? Dr. Vasilis Kouranos, London, UK
- CS treatment and management; known knowns and known unknowns. Dr. David Birnie, Ottawa, Canada
- In Montreal - Dr. Genevieve Giraldeau, Montreal, Canada
- In London - Dr. Vasilis Kouranos, London, UK
Sudden cardiac death risk stratification and device therapy for CS patients which device for what patients and what to expect in follow-up Dr. Jordana Kron, Virginia Commonwealth University, USA
- Case 1 – Dr. Alessandro De Bortoli, Ottawa, Canada
- Case 2 - Dr. Mario Senechal, Quebec City
- Case 3 - Dr. Genevieve Giraldeau, Laval, Canada
Taught by
University of Ottawa Heart Institute
